Clinical profile of long-term survivors and nonsurvivors with type 2 diabetes

Diabetes Care

Volumn 36, Issue 8, 2013, Pages 2190-2197

  Mohan, Viswanathan ^a,b,c   Rani, Coimbatore Subramanian Shanthi ^a   Amutha, Anandakumar ^a   Dhulipala, Sravan ^a   Anjana, Ranjit Mohan ^a   Parathasarathy, Balasubramanian ^a,c   Unnikrishnan, Ranjit ^a  

^a Research Foundation   (India)

^b Dr Mohan's Diabetes Specialties Centre   (India)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LIPID;

ADULT; AGE DISTRIBUTION; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE REGULATION; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; EYE PHOTOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; KIDNEY FAILURE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; PERCEPTIVE THRESHOLD; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RETROSPECTIVE STUDY; SURVIVOR; SYSTOLIC BLOOD PRESSURE; TERTIARY CARE CENTER; VIBRATION SENSE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMPLICATION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; MORTALITY; PHYSIOLOGY;

ADULT; AGED; ANKLE BRACHIAL INDEX; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDIA; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SURVIVORS;

EID: 84885980436     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1193     Document Type: Article

References (42)

1. Zargar AH, Wani AI, Masoodi SR, Laway BA, Bashir MI. Mortality in diabetes mellitusddata from a developing region of the world. Diabetes Res Clin Pract 1999; 43:67-74
2. Anjana RM, Pradeepa R, Deepa M, et al; ICMR-INDIABCollaborative StudyGroup. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMRINDIAB) study. Diabetologia 2011;54: 3022-3027
3. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-230
4. International Diabetes Federation. IDF Diabetes Atlas, 5th ed. Brussels, Belgium, International Diabetes Federation, 2011
5. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999;84:137-144
6. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-386
7. Ramachandran A, Snehalatha C, Kapur A, et al; Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001;44:1094-1101
8. Mohan V, DeepaM, Deepa R, et al. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South Indiadthe Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 2006;49:1175-1178
9. Mohan V, Radhika G, Sathya RM, Tamil SR, Ganesan A, Sudha V. Dietary carbohydrates, glycaemic load, food groups and newly detected type 2 diabetes among urban Asian Indian population in Chennai, India (Chennai Urban Rural Epidemiology Study 59). Br J Nutr 2009;102: 1498-1506
10. Mohan V, Gokulakrishnan K, Deepa R, Shanthirani CS, Datta M. Association of physical inactivity with components of metabolic syndrome and coronary artery diseasedthe Chennai Urban Population Study (CUPS no. 15). Diabet Med 2005; 22:1206-1211
11. Abate N, Chandalia M, Satija P, et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 2005;54:1207-1213
12. Vimaleswaran KS, Radha V, Ghosh S, et al. Peroxisome proliferator- activated receptorgamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians. Diabet Med 2005;22:1516-1521
13. Kooner JS, Saleheen D, Sim X, et al; DIAGRAM; MuTHER. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 2011;43: 984-989
14. Radha V, Mohan V. Genetic predisposition to type 2 diabetes among Asian Indians. Indian J Med Res 2007;125:259-274
15. Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001;86:5366-5371
16. Bain SC, Gill GV, Dyer PH, et al. Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med 2003;20:808-811
17. Sun JK, Keenan HA, Cavallerano JD, et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care 2011;34:968-974
18. Pradeepa R, Prabu AV, Jebarani S, Subhashini S, Mohan V. Use of a large diabetes electronic medical record system in India: clinical and research applications. J Diabetes Sci Tech 2011;5:543-552
19. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure;National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572
20. World Health Organization (WHO). The Asia Pacific Perspective. Redefining Obesity and Its Treatment. International Association for the Study of Obesity and International Obesity Task Force. Melbourne, International Diabetes Institute, 2000
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497
22. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographsdan extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991;98(Suppl):786-806
23. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005;46:2328-2333
24. Unnikrishnan RI, Rema M, Pradeepa R, et al. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007;30:2019-2024
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-470
26. Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES- 55). Diabet Med 2008;25:407-412
27. Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan V; The Chennai Urban Population Study (CUPS). Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study. Diabetes Care 2000;23: 1295-1300
28. Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JPH, Pinkney JH. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J 2006;82:280-284
29. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001;24:1936-1940.
30. Mohan V, Shanthirani CS, Deepa M, Deepa R, Unnikrishnan RI, Datta M. Mortality rates due to diabetes in a selected urban south Indian populationdthe Chennai Urban Population Study [CUPSd 16]. J Assoc Physicians India 2006;54:113-117
31. Zhang PH, Chen ZW, Lv D, et al. Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China. BMC Public Health 2012; 12:567
32. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012;55:1577-1596
33. Buse J. Statin treatment in diabetes mellitus. Clin Diabetes 2003;21:168-172
34. Sen K, Misra A, Kumar A, Pandey RM. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract 2002;56:1-11
35. Elisaf M, Mikhailidis DP. Statins and renal function. Angiology 2002;53:493-502
36. Fried LF, Forrest KY, Ellis D, Chang Y, Silvers N, Orchard TJ. Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes. J Diabetes Complications 2001;15:113-119
37. Amutha A, Datta M, Unnikrishnan IR, et al. Clinical profile of diabetes in the young seen between 1992 and 2009 at a specialist diabetes centre in south India. Prim Care Diabetes 2011;5:223-229
38. Raymond NT, Paul O'Hare J, Bellary S, Kumar S, Jones A, Barnett AH; UKADS Study Group. Comparative risk of microalbuminuria and proteinuria in UK residents of south Asian and white European ethnic background with type 2 diabetes: a report from UKADS. Curr Med Res Opin 2011;27(Suppl. 3):47-55
39. Bhansali A, Chattopadhyay A, Dash RJ. Mortality in diabetes: a retrospective analysis from a tertiary care hospital in North India. Diabetes Res Clin Practice 2003;60; 119-124.
40. Tekin N, Baskan M, Yesilkayali T, Karabay O. Prevalence of peripheral arterial disease and related risk factors in Turkish elders. BMC Fam Pract 2011;12:1-6
41. Tseng CH, Tseng FH, Chong CK, et al. Angiotensin-converting enzyme genotype and peripheral arterial disease in diabetic patients. Exp Diabetes Res 2012;2012:1-7
42. Mohan V, Deepa R, Rani SS, Premalatha G; Chennai Urban Population Study (CUPS No.5). Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001;38:682-687